It is apparent that study of the mechanisms of action of PDE4 drugs in a variety of human diseases, including lung disease, has enabled progress on understanding fundamental disease mechanisms in COPD and pulmonary fibrosis. Here, PDE4A is linked to pulmonary fibrosis.